EKA Ventures
EKA Ventures is a London-based early-stage impact venture capital firm founded in 2018 by Jon Coker and Camilla Dolan, investing at seed and Series A in UK consumer-technology companies across sustainable consumption, consumer healthcare and the inclusive economy. It raised a GBP 68 million Fund I (final close 2021) and a GBP 80 million (USD 107 million) Fund II (2026), bringing total assets under management to USD 200 million and making it the UK's largest early-stage impact VC. Eka Ventures LLP is registered at UK Companies House under number OC425032 and is authorised and regulated by the UK Financial Conduct Authority under firm reference number 848631.
Key facts
Recent exits
Coverage notes
2 funds tracked, 23 portfolio companies (22 active · 1 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund EKA Ventures has raised, with its portfolio companies. Hand-checked from public filings.
Eka Ventures Fund II2026 · 0yr€80M5 active
Unrealized
5 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Conveyd | Fintech | UK | 2025 |
| Cyclana Bio | Biotech | UK | 2025 |
| Ditto Daily | Consumer | UK | 2025 |
| Hesta Health | Healthcare | UK | 2025 |
| Medly AI | EdTech | UK | 2025 |
Eka Ventures Fund IImpact2021 · 5yr€80M17 active · 1 realized
Unrealized
17 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| 32Co | HealthTech | UK | 2024 |
| Airhive | ClimateTech | UK | 2024 |
| Axle | Energy | UK | 2023 |
| Byway | Consumer | UK | 2021 |
| Flok Health | HealthTech | UK | 2022 |
| Foresight Data Machines | AI/ML | UK | 2022 |
| Hived | Logistics | UK | 2021 |
| Hylo | Consumer | UK | 2022 |
| Isla | HealthTech | UK | 2023 |
| Jude | HealthTech | UK | 2022 |
| MakeSense | MedTech | UK | 2024 |
| Oxford Cancer Analytics | Biotech | UK | 2022 |
| Paired | Consumer | UK | 2021 |
| Sourceful | Industrials | UK | 2021 |
| Sustained | ClimateTech | UK | 2021 |
| Urban Jungle | InsurTech | UK | 2022 |
| XRlabs | MedTech | UK | 2024 |
Saved GPs appear in your watchlist, one click from your workspace.
About EKA Ventures
EKA Ventures is the UK's largest early-stage impact venture capital firm with approximately $200 million of total assets across Fund I and Fund II as of December 2024 (Fund II $107 million / £80 million closed late 2024 / early 2025), headquartered in London. The firm was founded in 2018 by Jon Huggins and Camilla Richards and operates as a partner-owned independent FCA-regulated (FRN 848631) B Corp certified VC.
Investment thesis
EKA Ventures deploys capital through two flagship funds (Fund I 2020, Fund II 2024-2025), targeting pre-seed and seed-stage UK impact venture capital leading or co-leading 90% of deals with approximately $2 million average initial cheque across consumer-led mega trends spanning Life, Health and Sustainability. Sector focus spans consumer health and femtech, climate tech, sustainable supply chains, preventative healthcare, consumer goods and fintech and legaltech. Fund II plans up to 30 UK startups. Geographic deployment is UK-focused. The founder-aligned thought partner model provides strategic guidance beyond capital.
Recent activity
Recent realised exits include consumer health and fitness apps (Runna acquired by Strava, April 2025). Recent acquisitions include femtech and menstrual health (DITTO Daily £1.35 million pre-seed lead, August 2025) plus active deployment across Hived (last-mile logistics), Jude (urinary health), Flok Health (musculoskeletal AI) and Foresight Data Machines. The platform continues active deployment of Fund II across the UK impact thesis. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€309.0BUnited Kingdom·€15.4BUnited Kingdom·€12.7BUnited Kingdom·€11.7BUnited Kingdom·€6.4BUnited Kingdom·€4.1BUnited Kingdom·€3.5BUnited Kingdom·€2.3BUnited Kingdom·€2.3BUnited Kingdom·€1.8BUnited Kingdom·€1.8BUnited Kingdom·€1.6B